| NAME |
DENOSUMAB 60MG/ML INJ,SYRINGE,1ML |
| VA GENERIC NAME |
DENOSUMAB |
| DOSAGE FORM |
INJ,SOLN |
| FDA MED GUIDE |
Denosumab_(Prolia)_(2022).pdf |
| FORMULARY DESIGNATOR |
PA-F |
| ACTIVE INGREDIENTS |
|
| NATIONAL FORMULARY INDICATOR |
YES |
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
60 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| UNITS |
MG/ML |
| NATIONAL FORMULARY NAME |
DENOSUMAB INJ,SOLN |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
DENOSUMAB 60MG/ML INJ SYRINGE 1ML |
| VA PRODUCT IDENTIFIER |
D0857 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
SYR |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4030069 |
| EFFECTIVE DATE/TIME |
-
- 2010-09-08 00:00:00
- STATUS: ACTIVE
|
